MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 6, 2013, Pages 3479-3482

  Ashkavandi, Zohreh Jaafari ^a   Najvani, Ali Dehghani ^a   Tadbir, Azadeh Andishe ^a   Pardis, Soheil ^a   Ranjbar, Mohammad Ali ^a   Ashraf, Mohammad Javad ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Benign; immunohistochemistry; Ki 67; Malignant; MCM3; Salivary gland tumors

Indexed keywords

EID: 84882583581     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.6.3479     Document Type: Article

References (28)

1. Agarwal JP, Jain S,Gupta T, et al (2008). Intraoral adenoid cystic carcinoma: prognostic factors and outcome. Oral Oncol, 44, 986-93.
2. Alison MR, Hunt T, Forbes SJ (2002). Minichromosome maintenance (MCM) proteins may be pre-cancer markers. Gut, 50, 290-1.
3. Brown DC, Gatter KC (2002). Ki67 protein: the immaculate deception?. Histopathol, 40, 2-11.
4. Chevalier S, Blow JJ (1996). Cell cycle control of replication initiation in eukaryotes. Curr Opin Cell Biol, 8, 815-21.
5. Constantinos G, Stephanie V, Philippe V, Stamatios T (2010). MCM proteins as diagnostic and prognostic tumor marker in the clinical setting. Histol Histopathol, 25, 351-70.
6. de Andrade BA, Leon JE, Carlos R, et al (2012). Expression of minichromosome maintenance 2, Ki-67, and geminin in oral nevi and melanoma. Ann Diag Pathol, 17, 32-6.
7. Forsburg SL (2004). Eukaryotic MCM proteins: beyond replication initiation. Microbiol Mol Biol Rev, 68, 109-31.
8. Freeman A, Morris LS, Mills AD, et al (1999). Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res, 5, 2121-32.
9. Ghazy SE, Helmy IM, Baghdadi HM (2011). Maspin and MCM2 immunoprofiling in salivary gland carcinomas. Diagn Pathol, 6, 89.
10. Gonzalez MA, Pinder SE, Callagy G, et al (2003). Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol, 21, 4306-13.
11. Ito FA, Ito K, Vargas PA, de Almeida OP, Lopes MA (2005). Salivary gland tumors in a Brazilian population: a retrospective study of 496 cases. Int J Oral Maxillofac Surg, 34, 533-6.
12. Kodani I, Shomori K, Osaki M, et al (2001). Expression of minichromosome maintenance 2(MCM2), Ki-67,and cell-cycle- related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa. Pathobiology, 69, 150-8.
13. Korkolopoulou P, Givalos N, Saetta A, et al (2005). Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Hum Pathol, 36, 899-907.
14. Li J, Deng M, Wei Q, Liu T, et al (2011). Phosphorylation of MCM3 protein by cyclin E/cyclin-dependent kinase 2 (Cdk2) regulates its function in cell cycle. J Biol Chem, 46, 39776-85.
15. Mac Callum DE, Hall PA (2000). The location of PKI67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J Pathol, 190, 537-44.
16. Meng MV, Grossfeld GD, Williams GH, et al (2001). Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res, 7, 2712-8.
17. Liu M, Li JS, Tian DP, et al (2013). MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer. Histol Histopathol, 28, 481-92.
18. Nagao T, Sato E, Inoue R, et al (2012). Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice. Acta Histochem Cytochem, 45, 269-82.
19. Nurhan G, Nil C, Fatih C (2012). Ki-67 and MCM-2 in dental follicle and odontogenic cysts: the effects of inflammation on proliferative markers. Sci World J, [Epub ahead of print].
20. Pich A, Chiusa L, Navone R (2004). Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol, 15, 1319-29.
21. Speight P, Barrett A (2004). Salivary gland tumors. Oral Dis, 8, 229-40.
22. Szelachowska J, Dziegiel P, Jelen-Krzeszewska J, et al (2006). Jelen M, Matkowski R, Pomiencko A, et al. MCM-2 protein expression predicts prognosid better than ki-67 antigen in oral cavity squamocellular carcinoma. Anticancer Ref, 26, 2473-8.
23. Tadbir AA, Pardis S, Ashkavandi ZJ, et al (2012). Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors. Asian Pas J Cancer Prev, 13, 5155-9.
24. Van Diest PJ, vander Wall E, Baak JP (2004). Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol, 57, 675-81.
25. Van Oijen MG, Medema RH, Slootweg PJ, Rijksen G (1998). Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol, 110, 24-31.
26. Vargas P, Cheng W, Barrett A, Craig G, Speight P (2008). Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumors. J Oral Pathol Med, 37, 309-18.
27. Yang C, Wen Y, Li H, et al (2011). Overexpression of minichro mosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Oncol Rep, 27, 135-42
28. Youn SL, Seon-Ah Ha, Hae JK, et al (2010) Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma. Exp Mol Pathol, 88, 138-42.